Among these alternative splicing events, RBM4, Nova1, SRSF6, and vascular endothelial growth factor 165 (VEGF165) comprised a splicing cascade in a consensus sequence-dependent manner which manipulated the migration and angiogenetic signature of CRC cells. This evidence concerns the gene RBM4 and colorectal carcinoma.